Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00842439 · ClinicalTrials.gov registry record · NA

Healthy Brains & Behavior: Understanding and Treating Youth Aggression

A NA study of Aggression, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
335
Enrollment target
1
Study location

NCT00842439: Completed NA study of Aggression, sponsored by University of Pennsylvania.

NCT00842439 is a NA study of Aggression that has completed, run by University of Pennsylvania. The registered enrollment target is 335 participants, above the 139-participant average among 21 other Aggression trials with a reported enrollment target (141% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00842439, a NA study of Aggression, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
335 participants
Enrollment target
1
Study location

Study Summary

Understanding the joint neurobiological and social bases to aggression is critical to future attempts to tackle this major public health problem. The overarching goals are: (a) to conduct perhaps the most systematic integration of biosocial risk factors for childhood aggression in order to predict later aggression, (b) to conduct one of the very few biosocial interventions on childhood aggression, (c) to predict and treat two fundamentally different manifestations of aggression proactive and reactive aggression which likely have different etiologies and responsiveness to treatment. The specific aims are: (1) to assess biological (genetic, neurocognitive, brain imaging, neuroendocrinological, neurotoxin, psychophysiological, nutritional), psychosocial (neighborhood, family, school, peer, psychological) and psychiatric (ADHD, CD, ODD, depression, anxiety, PTSD, schizophrenia-spectrum) risk factors for male and female aggression in order to better predict later aggression, (2) to improve prediction by identifying the genetic, neuroimaging, psychophysiological, and neuroendocrinological factors that protect children who are socially at risk for a violence outcome, (3) to develop a genetic mouse model of aggression to test the effectiveness of nutritional interventions in reducing aggression, (4) to begin to develop a new biosocial approach to the treatment and prevention of aggression, based on both cognitive-behavioral and nutrition interventions, (5) to assess the differential prediction and treatment of two fundamental variants of child aggression: proactive and reactive aggression. The human sample will consist of 500 male and female 11-year-old children drawn from high-risk communities in Philadelphia. Three hundred participants will engage in a baseline assessment for risk factors for aggression, and then be randomly assigned to one of four three-month intervention programs: treatment-as-usual, cognitive-behavioral intervention, nutrition supplementation, or CBI +

Conditions Studied

Interventions

  • BEHAVIORAL CBI
  • DIETARY_SUPPLEMENT NUT

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 335 participants
Start Date 2009-02
Est. Completion 2012-08
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT00842439 record still lists

NCT00842439 is an interventional study that assigns participants to a tested intervention. The registered 335 participants enrollment target is mid-sized for trials with a published cap, above the 139-participant average among 21 other Aggression trials with a reported enrollment target (141% higher).

The record links to 1 condition, with Aggression appearing as the primary indexed condition, and to 2 interventions - of which CBI is the first listed.

NCT00842439 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00842439 about?

NCT00842439 is a clinical study titled "Healthy Brains & Behavior: Understanding and Treating Youth Aggression". Understanding the joint neurobiological and social bases to aggression is critical to future attempts to tackle this major public health problem. The overarching goals are: (a) to conduct perhaps the most systematic integration of biosocial risk factors for childhood aggression in order to predict l...

What is the current status of trial NCT00842439?

This trial is currently completed. It is a NA study. The enrollment target is 335 participants. The study started on 2009-02. Estimated completion is 2012-08.

What conditions does trial NCT00842439 study?

This clinical trial studies the following conditions: Aggression.

What interventions are being tested in trial NCT00842439?

The interventions under investigation include: CBI (BEHAVIORAL), NUT (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00842439?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00842439 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aggression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00842439's enrollment target sits among peer trials

335 3rd of 21 higher than 19 of 21 other Aggression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aggression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04134754 · 335 participants · NA

    Carbon Dioxide (CO2) Chemosensitivity and SUDEP

  • NCT05554406 · 335 participants · Phase 2

    Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

  • NCT06183437 · 335 participants · Phase 4

    The STOP-MED CTRCD Trial

  • NCT06885177 · 335 participants · NA

    TECTONIC CAD IVL IDE Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00842439, the US trial registry maintained by the National Library of Medicine. NCT00842439 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.